Skip to main content
Log in

Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis

  • Meta- Analysis
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Current knowledge about the ovarian reserve in patients with type 1 diabetes is inconsistent and based on studies with small sample size. This meta-analysis aimed to produce a comprehensive evaluation on the ovarian reserve of type 1 diabetes female patients and to analyze the associated factors with the ovarian reserve.

Methods

Systematic searches were conducted for studies published from the inception to December 2021. Original human observational studies either with case-control, cross-sectional, or longitudinal design evaluating ovarian reserve markers between type 1 diabetes patients and healthy controls were included. Levels of anti-müllerian hormone (AMH), follicle-stimulating hormone (FSH), and estradiol (E2) were extracted.

Results

It was indicated that women with type 1 diabetes were associated with decreased levels of AMH compared with healthy controls (weighted mean difference [WMD] −0.70 ng/ml, 95% confidence intervals [CI] −1.05 to −0.34 ng/ml, P = 0.0001). Subgroup analyses stratified by age showed that adult patients with type 1 diabetes were associated with decreased levels of AMH (WMD −0.70 ng/ml, 95% CI −1.06 to −0.34 ng/ml, P = 0.0001) and FSH (WMD −1.07 IU/L, 95% CI −1.75 to −0.39 IU/L, P = 0.002) compared with healthy controls. Meta-regression analysis showed no significant correlation between AMH, FSH, and clinical factors, while level of E2 was negatively correlated with daily insulin doses and glycosylated hemoglobin A1c (HbA1c) values.

Conclusion

According to this meta-analysis, type 1 diabetes might be associated with decreased AMH levels. Further studies using different markers and fertility outcomes focus on the ovarian reserve of women with type 1 diabetes are urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. S.U. Park, L. Walsh, K.M. Berkowitz, Mechanisms of ovarian aging. Reproduction 162, R19–33 (2021)

    Article  CAS  PubMed  Google Scholar 

  2. H. Xu, M. Zhang, H. Zhang, H. Zhang, K. Alpadi, K.L. Wang, R. Li, J. Qiao, Clinical applications of serum anti-müllerian hormone measurements in both males and females: an update. Innovation 9, 100091 (2021)

    Google Scholar 

  3. L.M.E. Moolhuijsen, J.A. Visser, Anti-müllerian hormone and ovarian reserve: update on assessing ovarian function. J. Clin. Endocrinol. Metab. 105, 3361–3373 (2020)

    Article  PubMed Central  Google Scholar 

  4. D.B. Seifer, G. Lambert-Messerlian, J.W. Hogan, A.C. Gardiner, A.S. Blazar, C.A. Berk, Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril. 67, 110–114 (1997)

    Article  CAS  PubMed  Google Scholar 

  5. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, C.B. Lambalk, A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update 12, 685–718 (2016)

    Article  Google Scholar 

  6. S.L. Broer, J. van Disseldorp, K.A. Broeze, M. Dolleman, B.C. Opmeer, P. Bossuyt, M.J. Eijkemans, B.W. Mol, F.J. Broekmans; IMPORT study group, Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum. Reprod. Update 19, 26–36 (2013)

    Article  PubMed  Google Scholar 

  7. A. Lass, J. Skull, E. McVeigh, R. Margara, R.M. Winston, Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in vitro fertilization can predict poor response. Hum. Reprod. 12, 294–297 (1997)

    Article  CAS  PubMed  Google Scholar 

  8. International Diabetes Federation, IDF Diabetes Atlas, 9th ed. https://diabetesatlas.org/atlas/ninth-edition/. Accessed 1 Feb 2021.

  9. K. Kjaer, C. Hagen, S.H. Sandø, O. Eshøj, Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J. Clin. Endocrinol. Metab. 75, 524–529 (1992)

    CAS  PubMed  Google Scholar 

  10. K.K. Danielson, M. Palta, C. Allen, D.J. D’Alessio, The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J. Clin. Endocrinol. Metab. 90, 6466–6471 (2005)

    Article  CAS  PubMed  Google Scholar 

  11. J.S. Dorman, A.R. Steenkiste, T.P. Foley, E.S. Strotmeyer, J.P. Burke, L.H. Kuller, C.K. Kwoh, Menopause in type 1 diabetic women: is it premature? Diabetes 50, 1857–1862 (2001)

    Article  CAS  PubMed  Google Scholar 

  12. N. Soto, G. Iñiguez, P. López, G. Larenas, V. Mujica, R.A. Rey, E. Codner, Anti-müllerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum. Reprod. 24, 2838–2844 (2009)

    Article  CAS  PubMed  Google Scholar 

  13. C. Kim, C. Karvonen-Gutierrez, S. Kong, V. Arends, M. Steffes, D.S. McConnell, J.F. Randolph Jr, S.D. Harlow, Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study. Fertil. Steril. 106, 1446–1452 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. F. Yarde, W. Spiering, A. Franx, F.L.J. Visseren, M.J.C. Eijkemans, H.W. de Valk, F.J.M. Broekmans; OVADIA Study Group, Association between vascular health and ovarian ageing in type 1 diabetes mellitus. Hum. Reprod. 31, 1354–1362 (2016)

    Article  CAS  PubMed  Google Scholar 

  15. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rostom, A., Dubé, C., Cranney, A., Saloojee, N., Sy, R., Garritty, C., Sampson, M., Zhang, L., Yazdi, F., Mamaladze, V., Pan, I. McNeil, J., Moher, D., Mack, D., Patel, D. Celiac disease. Evid. Rep. Technol. Assess. 104, 1–6 (2004).

  17. S.P. Hozo, B. Djulbegovic, I. Hozo, Estimating the mean and variance from the median, range, and the size of a sample. Bmc. Med. Res. Methodol. 5, 13 (2005)

    Article  PubMed  PubMed Central  Google Scholar 

  18. V. Calcaterra, R.E. Nappi, G. Pelizzo, A. De Silvestri, R. Albertini, M. De Amici, E. Tenuta, F. Vinci, C. Mameli, G. Zuccotti, Insulin resistance and potential modulators of ovarian reserve in young reproductive-aged women with obesity and type 1 diabetes. Gynecol. Endocrinol. 37, 823–830 (2021)

    Article  CAS  PubMed  Google Scholar 

  19. E. Codner, D. Mook-Kanamori, R.A. Bazaes, N. Unanue, H. Sovino, F. Ugarte, A. Avila, G. Iñiguez, F. Cassorla, Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J. Clin. Endocrinol. Metab. 90, 3939–3945 (2005)

    Article  CAS  PubMed  Google Scholar 

  20. E. Codner, N. Soto, P. Lopez, L. Trejo, A. Avila, F.C. Eyzaguirre, G. Iniguez, F. Cassorla, Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 91, 2250–2256 (2006)

    Article  CAS  PubMed  Google Scholar 

  21. A. Łebkowska, A. Adamska, M. Karczewska-Kupczewska, A. Nikołajuk, E. Otziomek, R. Milewski, M. Górska, S. Wołczyński, I. Kowalska, Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Metabolism 65, 804–811 (2016)

    Article  PubMed  CAS  Google Scholar 

  22. P. Kadiroğulları, E. Demir, P.Y. Bahat, H. Kıyak, K.D. Seckin, Evaluation of relationship between HbA1c levels and ovarian reserve in patients with type 1 diabetes mellitus. Gynecol. Endocrinol. 36, 426–430 (2020)

    Article  PubMed  CAS  Google Scholar 

  23. L.S. Hassan, R.S. Monson, K.K. Danielson, Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls. Diabetes Metab. Res. Rev. 33, 2829 (2017)

    Article  CAS  Google Scholar 

  24. R. Tal, D.B. Seifer, Ovarian reserve testing: a user’s guide. Am. J. Obstet. Gynecol. 217, 129–140 (2017)

    Article  PubMed  Google Scholar 

  25. J.G. Regensteiner, S. Golden, A.G. Huebschmann, E. Barrett-Connor, A.Y. Chang, D. Chyu, C.S. Fox, C. Kim, N. Mehta, J.F. Reckelhoff, J.E.B. Reusch, K.M. Rexrode, A.E. Sumner, F.K. Welty, N.K. Wegner, B. Anton, Sex Differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 132, 2424–2447 (2015)

    Article  PubMed  Google Scholar 

  26. Practice Committee of the American Society for Reproductive Medicine, Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil. Steril. 103, e9–17 (2015)

    Google Scholar 

  27. Z. Jamil, S.S. Fatima, K. Ahmed, R. Malik, Anti-Müllerian hormone: above and beyond conventional ovarian reserve markers. Dis. Markers 2016, 5246217 (2016)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. M. Depmann, M.J. Faddy, Y.T. van der Schouw, P.H.M. Peeters, S.L. Broer, T.W. Kelsey, S.M. Nelson, F.J.M. Broekmans, The relationship between variation in size of the primordial follicle pool and age at natural menopause. J. Clin. Endocrinol. Metab. 100, e845–851 (2015)

    Article  CAS  PubMed  Google Scholar 

  29. M.R. Gohari, F.R. Tehrani, S. Chenouri, M. Solaymani-Dodaran, F. Azizi, Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone. Menopause 23, 839–845 (2016)

    Article  PubMed  Google Scholar 

  30. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A.C. Artenisio, G. Stabile, A. Volpe, Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update 16, 113–130 (2010)

    Article  PubMed  CAS  Google Scholar 

  31. F.R. Tehrani, H. Erfani, L. Cheraghi, M. Tohidi, F. Azizi, Lipid profiles and ovarian reserve status: a longitudinal study. Hum. Reprod. 29, 2522–2529 (2014)

    Article  CAS  PubMed  Google Scholar 

  32. N.M. Daan, B.C. Fauser, Menopause prediction and potential implications. Maturitas 82, 257–265 (2015)

    Article  PubMed  Google Scholar 

  33. M.L. Griffin, S.A. South, V.I. Yankov, R.A. Booth Jr, C.M. Asplin, J.D. Veldhuis, W.S. Evans, Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann. Med. 26, 331–340 (1994)

    Article  CAS  PubMed  Google Scholar 

  34. K. Kjaer, C. Hagen, S. Sando, O. Eshoj, Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulindependent diabetes mellitus compared to control subjects. J. Clin. Endocrinol. Metab. 75, 524–529 (1992)

    CAS  PubMed  Google Scholar 

  35. A. Yeshaya, R. Orvieto, D. Dicker, M. Karp, Z. Ben-Rafael, Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J. Fertil. 40, 269–273 (1995)

    CAS  Google Scholar 

  36. A.S. Chang, A.N. Dale, K.H. Moley, Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 146, 2445–2453 (2005)

    Article  CAS  PubMed  Google Scholar 

  37. S.A. Colton, P.G. Humpherso, H.J. Lees, S.M. Downs, Physiological changes in oocyte-cumulus cell complexes from diabetic mice that potentially influence meiotic regulation. Biol. Reprod. 69, 761–770 (2003)

    Article  CAS  PubMed  Google Scholar 

  38. C. Tatone, F. Amicarelli, M.C. Carbone, P. Monteleone, D. Caserta, R. Marci, P.G. Artini, P. Piomboni, R. Focarelli, Cellular and molecular aspects of ovarian follicle ageing. Hum. Reprod. Update 14, 131–142 (2008)

    Article  CAS  PubMed  Google Scholar 

  39. E. Diamanti-Kandarakis, C. Piperi, E. Patsouris, P. Korkolopoulou, D. Panidis, L. Pawelczyk, A.G. Papavassiliou, A.J. Duleba, Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem. Cell. Biol. 127, 581–589 (2007)

    Article  CAS  PubMed  Google Scholar 

  40. M.F. Wellons, J.J. Matthews, C. Kim, Ovarian aging in women with diabetes: an overview. Maturitas 96, 109–113 (2017)

    Article  CAS  PubMed  Google Scholar 

  41. R. Salvi, E. Castillo, M.J. Voirol, M. Glauser, J.P. Rey, R.C. Gailard, P. Vollenweider, F.P. Pralong, Gonadotropin-releasing hormone-expressing neurons immortalized conditionally are activated by insulin: implication of the mitogen-activated protein kinase pathway. Endocrinology 147, 816–826 (2006)

    Article  CAS  PubMed  Google Scholar 

  42. J.C. Brüning, D. Gautam, D.J. Burks, J. Gillette, M. Schubert, P.C. Orban, R. Klein, W. Krone, D. Müller-Wieland, C.R. Kahn, Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125 (2000)

    Article  PubMed  Google Scholar 

  43. J.M. Castellano, V.M. Navarro, J. Roa, R. Pineda, M.A. Sánchez-Garrido, D. García-Galiano, E. Vigo, C. Dieguez, E. Aguilar, L. Pinilla, M. Tena-Sempere, Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences. Endocrinology 150, 784–794 (2009)

    Article  CAS  PubMed  Google Scholar 

  44. B. Lawrenz, J. Henes, M. Henes, E. Neunhoeffer, M. Schmalzing, T. Fehm, I. Kïtter, Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus 20, 1193–1197 (2011)

    Article  CAS  PubMed  Google Scholar 

  45. W. Luo, P. Mao, L. Zhang, X. Chen, Z. Yang, Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis. Ann. Palliat. Med. 9, 207–215 (2020)

    Article  PubMed  Google Scholar 

  46. M.E. Clowse, S.C. Copland, T.C. Hsieh, S.C. Chow, G.S. Hoffman, P.A. Merkel, R.F. Spiera, J.C. Davis Jr, W.J. McCune, S.R. Ytterberg, E.W. St Clair, N.B. Allen, U. Specks, J.H. Stone; WGET Research Group, Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener’s). Arthritis Care. Res. 63, 1777–1781 (2011)

    Article  CAS  Google Scholar 

  47. C. Betterle, A. Rossi, S.D. Dalla Pria, A. Artifoni, B. Pedini, S. Gavasso, A. Caretto, Premature ovarian failure: autoimmunity and natural history. Clin. Endocrinol. 39, 35–43 (1993)

    Article  CAS  Google Scholar 

  48. H.F. Escobar-Morreale, B. Roldán, R. Barrio, M. Alonso, J. Sancho, H. de la Calle, R. García-Robles, High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 85, 4182–4187 (2000)

    CAS  PubMed  Google Scholar 

  49. H.F. Escobar-Morreale, M. Belén Roldán-Martín, Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care 39, 639–648 (2016).

    Article  CAS  PubMed  Google Scholar 

  50. N. Moslehi, S. Shab-Bidar, F.R. Tehrani, P. Mirmiran, F. Azizi, Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause 25, 1046–1055 (2018)

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all the doctors, nurses, and technicians for their practical work during the study at Department of Endocrinology and Metabolism, Peking University People’s Hospital.

Author contributions

X.C. and L.J. conceived and designed the review. W.Y., C.L., F.L., X.Z. identified reports and extracted data. X.C. and X.H. provided statistical advice and contributed to data interpretation. W.Y. drafted the paper. M.Z. helped revised the paper. All authors read and approved the final paper.

Funding

This study was supported by National Natural Science Foundation of China (No. 81903711, 81970698, 81970708) and Beijing Natural Science Foundation (No. 7202216).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiaoling Cai or Linong Ji.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, W., Lin, C., Zhang, M. et al. Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis. Endocrine 77, 205–212 (2022). https://doi.org/10.1007/s12020-022-03091-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03091-y

Keywords

Navigation